EN IT

updated 14.10.2019

Colon-IC Literature

6. Kojima T, Matsui T, Yasunobu Fujimitsu Y, Hiroshi Kojima H, Uno H, Hiramatsu K, Inagaki H, Oda K, Ishiyama A, Iwata N, Nakayama G, Kodera Y. Titration of serum CEA, p53 antibodies and CEA-IgM complexes in 142 patients with colorectal cancer and 150 healthy blood donors. Ann Cancer Res Therap. 19(1):15-19. 2011. doi: 10.4993/acrt.19.15
5. Zorzetto V, Rugge M, Parente P, Zaninotto G, Castoro M, Ruol A, Maddalo G, Zanatta L, Farinti F. SCCA-IgM and CEA-IgM in Barrett's esophagus and esophageal cancers. Dig Liver Dis. 43:S156. 2011.
4. Kojima T, Yoshikawa K, Matsui T, Kodera Y, Kojima H. Detection of circulating CEA-IgM complexes in early stage gastric cancer. Ann Cancer Res Therap. 18(2):69-72. 2010. doi: 10.4993/acrt.18.69
3. Savitskaya Y, Rico G, Linares L, Gonzalez R, Tellez R, Estrada E, Marin N, Martinez E, Alfaro A, Ibarra C. Circulating Natural IgM Antibodies Against Angiogenin in the Peripheral Blood Sera of Patients with Osteosarcoma as Candidate Biomarkers and Reporters of Tumorigenesis. Biomark Cancer. 2:65-78. 2010. doi: 10.4137/BIC.S6040
2. Kojima T, Yoshikawa K, Matsui T, Kodera Y, Kojima H. Titration of serum CEA, p53 antibodies and CEA-IgM complexes in patients with colorectal cancer. Mol Med Report. 2(3):477-80. 2009. doi: 10.3892/mmr_00000124
1. Castaldi F, Marino M, Beneduce L, Belluco C, De Marchi F, Mammano E, Nitti D, Lise M, Fassina G. Detection of circulating CEA-IgM complexes in early stage colorectal cancer. Int J Biol Markers. 20(4):204-8. 2005.